Thu, 31 Mar



4th Bladder Cancer Translational Research Meeting 2022

Tickets are not on sale
See other events

Time & Location

31 Mar, 09:30 – 16:00

London, Strand, London WC2R 2LS, UK

About the event

The Bladder Cancer Research Centre (University of Birmingham) and the Translational Oncology & Urology Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 4th Bladder Cancer Translational Research Meeting - a fully interactive bladder cancer clinical research meeting led by a international expert panel of clinicians and scientists in the U.K. The forum is designed to bridge the gap between science and clinical practice and will cover the spectrum of bladder cancer research in oncology, urology, nursing, epidemiology, immuno- and molecular biology.

Despite the substantial disease burden for patients and healthcare providers, bladder cancer only receives 0.6% of cancer research spending. This meeting will thus provide an opportunity to enhance collaborations across the UK and internationally and allow networking opportunities between clinicians and scientists allowing participants to anticipate crucial observations in the clinical practice to inform research activities and vice versa. Marrying these two diverse disciplines will enable healthcare systems to provide more efficient outcome-driven patient-centred interventions in the field of bladder cancer.

In addition to engagement through interactive sessions with high impact speakers, we invite participants from their respective units to submit and present their research. Three high impact abstracts will be selected for an oral presentation and the best oral and poster presentations will be awarded with a prize.

King’s College London, the Strand Campus, The Great Hall is the venue for this translational research event on 31st March 2022 and we look forward to welcoming delegates to another exciting meeting.

Abstract submission:

Abstracts need to be submitted to 15th March 2022. Abstracts should be structured (background, methods, results, conclusion) and be no longer than 300 words.  All authors should be listed, including their affiliation.

Share this event